Zhang S, Chen Y, Tian C, He Y, Tian Z, Wan Y, et al. Dual-target inhibitors based on BRD4: Novel therapeutic approaches for cancer. Curr Med Chem. 2021;28:1775–95.

Article  CAS  PubMed  Google Scholar 

Dadashpour S, Emami S. Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms. Eur J Med Chem. 2018;150:9–29.

Article  CAS  PubMed  Google Scholar 

Zhang Z, Xing X, Guan P, Song S, You G, Xia C, et al. Recent progress in agents targeting polo-like kinases: Promising therapeutic strategies. Eur J Med Chem. 2021;217:113314.

Article  CAS  PubMed  Google Scholar 

Kaushik NK, Kaushik N, Attri P, Kumar N, Kim CH, Verma AK, et al. Biomedical importance of indoles. Molecules. 2013;18:6620–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wan Y, Fang G, Chen H, Deng X, Tang Z. Sulfonamide derivatives as potential anti-cancer agents and their SARs elucidation. Eur J Med Chem. 2021;226:113837.

Article  CAS  PubMed  Google Scholar 

Taber DF, Tirunahari PK. Indole synthesis: a review and proposed classification. Tetrahedron. 2011;67:7195–210.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu T, Song S, Wang X, Hao J. Small-molecule inhibitors of breast cancer-related targets: Potential therapeutic agents for breast cancer. Eur J Med Chem. 2021;210:112954.

Article  CAS  PubMed  Google Scholar 

Liu T, Wu Z, He Y, Xiao Y, Xia C. Single and dual target inhibitors based on Bcl-2: Promising anti-tumor agents for cancer therapy. Eur J Med Chem. 2020;201:112446.

Article  CAS  PubMed  Google Scholar 

Wan Y, Li Y, Yan C, Yan M, Tang Z. Indole: A privileged scaffold for the design of anti-cancer agents. Eur J Med Chem. 2019;183:111691.

Article  CAS  PubMed  Google Scholar 

Kumari A, Singh RK. Medicinal chemistry of indole derivatives: Current to future therapeutic prospectives. Bioorg Chem. 2019;89:103021.

Article  CAS  PubMed  Google Scholar 

Tantawy MA, Nafie MS, Elmegeed GA, Ali IAI. Auspicious role of the steroidal heterocyclic derivatives as a platform for anti-cancer drugs. Bioorg Chem. 2017;73:128–46.

Article  CAS  PubMed  Google Scholar 

de Sá Alves FR, Barreiro EJ, Fraga CA. From nature to drug discovery: the indole scaffold as a ‘privileged structure’. Mini Rev Med Chem. 2009;9:782–93.

Article  PubMed  Google Scholar 

Liu T, Wan Y, Liu R, Ma L, Li M, Fang H. Design, synthesis and preliminary biological evaluation of indole-3-carboxylic acid-based skeleton of Bcl-2/Mcl-1 dual inhibitors. Bioorg Med Chem. 2017;25:1939–48.

Article  CAS  PubMed  Google Scholar 

Kim SH, Sperry J. Synthesis of Alocasin A. J Nat Prod. 2015;78:3080–2.

Article  CAS  PubMed  Google Scholar 

Atadja P. Development of the pan-DAC inhibitor panobinostat (LBH589): successes and challenges. Cancer Lett. 2009;280:233–41.

Article  CAS  PubMed  Google Scholar 

Liu T, Wan Y, Xiao Y, Xia C, Duan G. Dual-target inhibitorsbBased on HDACs: Novel antitumor agents for cancer therapy. J Med Chem. 2020;63:8977–9002.

Article  CAS  PubMed  Google Scholar 

Xu G, Liu T, Zhou Y, Yang X, Fang H. 1-Phenyl-1H-indole derivatives as a new class of Bcl-2/Mcl-1 dual inhibitors: Design, synthesis, and preliminary biological evaluation. Bioorg Med Chem. 2017;25:5548–56.

Article  CAS  PubMed  Google Scholar